Comparison of Efficacy of Turmeric and Commercial Curcumin in Immunological Functions and Gene Regulation
Curcumin, the active constituent of turmeric possesses anti-cancer, anti-inflammatory and other properties. Earlier we have shown ethanolic extract of turmeric rhizome (ETE) activates murine lymphocytes and induces apoptosis in tumor cells. The present investigation is intended to study comparative efficacy of ETE as used by us and others and commercially available curcumin. The efficacy of these two substances was tested for immunostimulatory, anti-inflammatory and anti-oxidant properties in murine model. The expression of a few genes such as perforin, IL-2, IL-6, TNF-αand iNOS related with these events have also been studied at transcriptional level in T-cells. The ETE promoted cell division and functions of murine lymphocytes like production of NO¯, up regulation of perforin, IL-2 and IL-6 genes in course of functional differentiation much better than curcumin. The ETE acts better as anti-inflammatory agent in DTH reaction than curcumin. The better efficacy of ETE over curcumin could be due to presence of other compounds in the total extract than only diferuloylmethane as curcumin. The present study intends to recommend use of turmeric over curcumin whenever possible.
In Ayurveda (since Ca 1900 BC), turmeric, occupied a very important status both for curative and prophylactic measures and it is well incorporated into the culture of Indian subcontinent (Samy et al., 2008; Ammon and Wahl, 1991). The long list of uses of turmeric includes antiseptic (Grant, 2000; Thiemermann, 2006), anti-inflammatory (Arora et al., 1971; Chandra and Gupta, 1972; Singh and Aggarwal, 1995; Siddiqui et al., 2006; Chan, 1995; Abe et al., 1999; Gulucubuk et al., 2006; Cheshire and Baldwin, 1997; Jobin et al., 1999; Satoskar et al., 1986; Srivastava et al., 1995), antioxidant (Selvam et al., 1995; Bosca et al., 1997; Mukundan et al., 1993), antimalarial (Rasmussen et al., 2000; Koide et al., 2002), antitumor (Rafatullah et al., 1990; Kuttan et al., 1985; Sharma et al., 2001), anticarcinogenic (Thangapazham, et al., 2006; Yamamoto et al., 1997) and many others. Modern research has provided considerable scientific validation of these activities of turmeric for last several decades.
The yellow component of turmeric was first isolated in 1815 and was named Curcumin after its origin from Curcuma longa (Daube, 1870). Its chemical structure was determined by Roughley and Whiting (1973) to be a diferuloylmethane (Fig. 1). Then onwards extensive research work has been carried out with curcumin isolated from turmeric.
||Chemical structure of curcumin; 1: Parahydroxyl groups, 2:
Keto groups and 3: Double bonds
We showed Ethanolic Turmeric Extract (ETE) is inhibitory for murine fibrosarcoma
and Ehlrich ascitic carcinoma c ells both in vitro and in vivo
(Chakravarty et al., 2003; Chakravarty and Yasmin, 2005). Furthermore,
we found the novelty of turmeric as pro-stimulatory for immunocompetent cells,
activating T-cells for cytotoxic response against tumor cells (Chakravarty and
A thorough study of the comparative efficacy of total rhizome extract (ETE) as used by us and others and commercially available curcumin used by many is imperative. This was the objective of the present investigation.
The present investigation will compare the efficacy of ethanolic turmeric extract (ETE) and curcumin for immunostimulatory, anti-inflammatory and antioxidant properties in murine model. The expression of a few genes related with up and down regulation of these events has also been studied at transcriptional level in T-cells.
Perforin, a pore forming protein, plays great role in T-cell mediated cytotoxicity against targeT-cells including malignanT-cells (Henkart, 1989; Young, 1989; Tschopp and Nabholz, 1990; Kagi et al., 1994; Voskoboinik and Trapani, 2006). The gene encoding this pore forming molecules is not expressed in the naïve T-cells; but upon activation these molecules are produced in enhanced quantities. The level of expression of perforin gene with turmeric and curcumin treatment has been investigated. IL-2 and IL-6 belonging to type-I cytokines play major role in regulation of T-cell growth and differentiation (Stockinger and Veldhoen, 2007). That is why the expression of these two important regulatory cytokines has also been judged. TNF-α, a pleiotropic cytokine (Mace et al., 1988; Torisu et al., 2000; Rossi and Zlotnik, 2000; Balkwill and Montovani, 2001) is a powerful inducer of inflammatory response. TNF-α is one of the early genes to express with induction of various stimuli. The expression of this gene has been correlated with the degree of inflammatory reactions.
Nitric oxide is one of the important free radicals generated in activated T-cells (Niedbala et al., 1999, 2002). The expression of inducible nitric oxide synthase (iNOS) gene, responsible for NO generation, has also been taken into account to judge the efficacy of ETE and curcumin.
MATERIALS AND METHODS
The present investigation has been carried out at Immunology and Cell Biology Laboratory, Department of Zoology, University of North Bengal, Siliguri, India from early part of 2006 to November, 2008.
Animals: Inbred adult Swiss mice of both sexes, 8-12 weeks of age, were used for all experiments. Breeding nuclei were obtained from Indian Institute of Chemical Biology, Kolkata and are maintained with food and water ad libitum in our animal house.
Ethanolic turmeric extract preparation: Fresh rhizomes of turmeric (Curcuma longa L.) were obtained from the local market. After cleaning properly with water; 10 g of sample was crushed to a paste with mortar and pestle and 10 mL absolute alcohol was added to the paste and kept in a refrigerator at 4°C for overnight. The extract was then filtered through Whatman filter paper 1 and the filtrate was refiltered again through cellulose acetate Millipore filter paper (0.2 μm porosity, Sartorius) for sterilization and final solution obtained was aliquoted and stored at 4°C. To ascertain the dry weight of ETE, a volume of ETE in each batch was evaporated to dryness under reduced pressure (Rotary Vaccum, EYELA, Japan) at 55°C. The average dry weight of ETE was 0.435±0.032 mg mL-1. As suggested by our earlier study (Chakravarty et al., 2003; Chakravarty and Yasmin, 2005) 25 μL dose of ETE per animal was used in the present study. The equivalent amount of ethanol (25 μL) was used for control and this protocol was maintained for all the experiments.
Preparation of curcumin solution: Curcumin (mol wt. 368.39) was purchased from Acros Organic, New Jersey, USA (MFCD00008365). Curcumin was dissolved in ethanol at 10 μM concentration, found to be most effective (Chen et al., 2004, 2006; Yasmin, 2007) and 25 μL per animal was used in all the experiments.
Separation of T-lymphocytes: Ficoll and Hypaque gradient was employed for
the separation of lymphocytes from the total cell suspension (Berger and Edelson,
1979; Tamul et al., 1995). Spleen and lymph node cell suspensions in
3 mL of PBS were layered on Ficoll and Hypaque solution (Type IV, Sigma Co.,
USA) and centrifuged at 3000 rpm for 10 min. The band of lymphocytes at the
junction of Ficoll Hypaque and PBS was taken out and washed twice with PBS.
The ficoll-hypaque purified lymphocytes were finally resuspended in prewarmed
RPMI 1640 with 10% goat serum (Chaudhuri and Chakravarty, 1983). Then the lymphocyte
preparation was poured on a nylon wool fiber column for separation of B and
T-cells, as outlined by Julius and co-worker (Julius et al., 1973).
For preparing the column 0.1 g teased and sterilized nylon wool (Robins Scientific Corporation, USA), soaked in RPMI was gently packed in a 1 mL syringe. Each of the columns was loaded with cell suspensions (6x106 lymphocytes in 1 mL) and incubated at 37°C for 1 h. Non adherent T-cells were eluted out with an excess amount of warm RPMI and re-suspended in fresh medium. T-cells were counted with the help of haemocytometer (Chakravarty and Yasmin, 2005).
Cell cycle analysis by FACS: For cell cycle analysis, mice in three batches were injected intravenously with 25 μL of ETE or curcumin or alcohol. After 24 h, spleen cell suspension was prepared in PBS. To 1 mL of cell suspension containing 106 cells, 1 mL of 80% ethanol was added and the cells were fixed overnight at 4°C. Fixed cells were centrifuged, the supernatant was decanted off and 0.5 μL of 500 μg mL-1 (Standard 250 μg mL-1) RNAse A was added, followed by incubation for 45 min at 37°C. The 69 mM ethidium bromide was prepared in 38 mM sodium citrate. The cells were centrifuged and suspended in 0.5 mL of 69 mM ethidium bromide at room temperature for 30 min. Finally the cell cycle analysis was done in fluorescence activated cell sorter (FACS, Caliber, Becton Dickinson).
Delayed type hypersensitivity assay with 2,4-dinitrofluro benzene (DNFB): The delayed type hypersensitivity reaction depends on overall T-lymphocyte function. Primary sensitization of the mouse was carried out by applying 0.025 mL of 0.0001% DNFB made in acetone in the right foot pad subcutaneously and then resensitization was made with 0.025 mL of 0.000001% DNFB in the left foot pad on 8th day (Iizima and Katz, 1983). ETE or curcumin was administered intravenously 1 h prior to resensitization. The degree of erythema and induration was measured in terms of the diameter of the resensitized paw in cm from the ninth day onward. Size of the reaction spot was measured twice at right angles by a slide caliper and the average was taken as index for the reaction. The day of resensitization has been considered as 0 day for easy representation of the data.
Differential leukocyte count from DTH mice: Differential count of the leucocytes at the inflammation site of the DTH mice treated with ETE for 24 and 48 h after resensitization was made, to note the ratio of WBCs. For this, a thin and uniform film of the oozing fluid from the site of DTH reaction was prepared and stained with Leishmans stain for studying under microscope. The numbers of different types of white blood cells were expressed in percentage.
Separation of CD4+ helper T-cells from the spleen of DTH mice through Magnetic Assorted Cell Sorter (MACS) and their estimation: Cells of interest were specifically labeled with super paramagnetic MACS microbeads (Busch et al., 2004; Matheu and Cahalan, 2007; Stanciu and Djukanovic, 2000). Briefly, lymphocytes isolated from the spleen of DTH mice after 24 and 48 h of resensitization were suspended in PBS for separating CD4+ helper T-cells. Cell suspension was then centrifuged at 1000 rpm for 10 min and the cell pellet was resuspended at a concentration of 107 cells in 80 μL of fresh PBS. To this cell suspension, 20 μL of CD4+ (L3TH) microbeads (130-049-201, Miltenyi Biotech, Germany) were added and refrigerated for 15 min at 4 to 8°C. Cell suspension containing the microbeads were poured into the Magnetic Separator (MS) column. After collecting the total effluents of the unlabeled cell fractions the column was removed from the separator and placed upon a fresh collection tube. Finally, PBS was pipetted onto the MS column and the magnetic labeled cells were flushed out by firmly pushing a plunger into the column. The magnetic labeled live CD4+ T-cells were enumerated by trypan blue dye exclusion method with the help of a haemocytometer.
Estimation of TNF-α by ELISA: Solid phase sandwich ELISA KIT (PharMingen, USA) was utilized for the evaluation of serum TNF-α in DTH mice. Mouse TNF-α was assayed on microplates precoated with affinity purified polyclonal antibody specific for mouse TNF-α. The optical density of the plate was read at 450 nm. Concentration of TNF-α was extrapolated from the standard curve of TNF-α (Sirish-Kumar et al., 2003).
Biochemical estimation of free radical
Superoxide scavenging assay: Scavenging of superoxide radical (O2¯)
has been measured in a reaction mixture containing 0.1 M phosphate buffer (pH-7.4),
0.1 mM EDTA, 50 μM hematoxylin, 25 μL of ethanolic turmeric extract
(ETE) or curcumin or alcohol. The final volume of the reaction mixture was adjusted
to 2.5 mL by adding double distilled water (Martin et al., 1987). Superoxide
radical (O2¯) was generated from autoxidation of hematoxylin
and was detected by an increasing absorbance at 560 nm wavelength in a UV-visible
spectrophotometer (ELICO, SL164). The inhibition of autoxidation of hematoxylin
in presence of extract over the normal control was calculated.
Lipid peroxidation: Lipid peroxidation of lymphocytes in presence of turmeric extract was estimated according to Miller and Aust (1989). The reaction mixture containing 1x106 packed cells in 0.2 M phosphate buffer pH (7.4), with 20 mM Tris-HCl, 2 mM CuCl2, 10 mM ascorbic acid and 25 μL of ETE/curcumin and were incubated for 1 h at 37°C in humidified atmosphere containing 5% CO2 in air. In alcohol and normal controls, 25 μL ethanol or 25 μL double distilled water was added respectively instead of the extracts. Lipid peroxidation was measured as malonaldehyde (MDA) equivalent using TBA-TCA reagent (0.375% w/v TBA, 15% w/v TCA and 0.25 N HCl). OD value was determined spectrophotometrically at 535 nm. The percentage of inhibition of lipid peroxidation by the extracts and ethanol were calculated assuming the generation in normal control sets as maximum
Hydroxyl ion generation: Hydroxyl radical was generated from Fe2+-ascorbate-EDTA-H2O2 system (Fentons reaction) which attacks the deoxy D-ribose and a series of reaction that eventually resulted in the formation of malonaldehyde (MDA) (Halliwell et al., 1987). The reaction mixture contained 2.8 mM 2-deoxy D-ribose, 20 mM of KH2PO4-KOH (pH-7.4), 100 mM FeCl3, 104 μM EDTA, 1 mM H2O2, 1 mM ascorbic acid and 25 μL of ETE/curcumin. In control, 25 μL of ethanol was added instead of the extracts. The reaction mixture was incubated at 37°C in humidified atmosphere containing 5% CO2 in air for 1 h. Then 2 mL of thiobarbituric acid-trichloroacetic acid (TBA-TCA) reagent was added in each tube and boiled for 15 min. The color of the reaction mixture changes to a pink MDA-TBA chromogen which was finally measured at 532 nm in UV- spectrophotometer (ELICO, S L164). The level of inhibition in hydroxyl radical generation caused by ETE, curcumin and ethanol was calculated in reference to the level in normal control sets.
Nitric Oxide Synthase (NOS) activity: The NOS activity was determined by measuring the conversion of oxyhemoglobin to methemoglobin according to Jia et al. (1996). Briefly 1x106 packed lymphocytes were incubated for 2 h with 50 mM Tris-HCl buffer (pH 7.4), 10 mM L-arginine, 64 mM hemoglobin, with 25 μL of ETE at 37°C in humidified atmosphere containing 5% CO2 in air. After incubation, the mixture was centrifuged at 1000 rpm for 5 min and the optical density of supernatant was measured in UV-spectrophotometer (ELICO, S L164) at 535 nm. Results of NO production were expressed as pmol of NO produced/h.
To confirm that the production of NO was actually due to the activation of NOS, a competitive inhibitor of nitric oxide synthase (NOS), 10 μM NG methyl-L-arginine acetate ester (NAME) was added in a separate set of experimental tubes.
Gene expression analysis: Expression of the genes of interest in this study has been carried out using single cell RNA phenotyping procedure as outlined by Rappolee et al. (1988).
RNA isolation: The RNA was isolated from murine splenic T-cells using RNeasy Mini kit (74104, Qiagen, Valencia, USA.), as per manufacturers protocol. Briefly, 6x106 T-cells were homogenized with 300 μL RLT buffer and passing through a 2 mL syringe fitted with a 27 gauge needle. Three hundred microliter of 70% ethanol was added to the homogenate and collected in a spin column attached with a collection tube, supplied by the manufacturer. After a brief centrifugation for 15 sec at 10,000 rpm the collection tube was decanted and 500 μL of RW1 buffer was added to the spin column. Again the collection tube was decanted after a brief centrifugation and 500 μL of buffer RPE was added to the spin column. The column was centrifuged at 10000 rpm for 15 sec and was followed by a repeat wash with buffer RPE. Finally, the spin column was then fitted with a fresh collection tube and washed twice with 15 μL of DEPC treated water to come up with a total 30 μL RNA sample.
The concentration of RNA was measured spectrophotometrically at 400X dilution with Shimadzu UV-160, Japan. The extracted RNA was used for cDNA synthesis.
cDNA synthesis: The isolated RNA was used for First strand cDNA synthesis utilizing RevertAidTM First strand cDNA synthesis kit # K1621 from Fermentas following the manufacturers protocol. For synthesis of first strand cDNA the primer used for PCR amplification was oligo(dT13) synthesized by GMBH. cDNA constructed was stored at -20°C.
Primer utilized and amplification schedule: Primers were designed from various geneBank accession retrieved from PUBMED Data Bank as shown in Table 1, using primer program available on internet. The designed primers were synthesized by GMBH, Germany. Details of the primers are:
||Percentage of cells at different stages of cell cycle after
24 h in vivo treatment with ETE, curcumin and alcohol. Results are
expressed as Mean±SD. The percentage of cells with ETE treatment
at S phase is significantly different from the other three values at the
level of p<0.01
The PCR was performed for 35 cycles in 30 μL reaction mixture using thermocycler
(PeqLab, Germany) containing Taq DNA polymerase buffer, all four dNTPs, oligonucleotide
primers, Taq DNA polymerase and cDNA products. After amplification PCR products
were analyzed on 0.8% (w/v) agarose gel. The band density was quantified in
reference to the known concentration of lambda DNA (30 ng) through ImageAide,
Spectronics Corporation, NY.
Experimental sets and statistical analysis: In all the experiments, the responses of ETE and curcumin were compared with one set of control with same amount of ethanol and another set without any treatment. All the experiments were repeated at least thrice, each with triplicate samples. The data represents mean of all the repeat experiments and statistically analyzed with two way ANOVA method (Alin, 2006).
Cell cycle analysis: In vivo turmeric treatment for 24 h, induced proliferation of lymphocytes to an appreciable level compared to other treatment groups as revealed in FACS analysis. The percentage of cells entering into S phase was higher with ETE treatment (14.87%) compared to curcumin (7.38%); the difference was statistically significant. The count with curcumin was similar to the alcohol treated control (Table 1, Fig. 2).
Inhibition of DTH response after treatment: As ETE activates cell mediated immunity (Chakravarty et al., 2003; Chakravarty and Yasmin, 2005) so its effect on Delayed Type Hypersensitivity (DTH) response enacted by T-cells was also studied. The DTH was initiated upon 2,4-DNFB injection in the foot paw of mouse.
The untreated mice had the swelling all through the study period of 9 days
(Fig. 3). The ETE and curcumin (10 μM) treatment reduced
the swelling noticeably at all the points compared to the controls (Fig.
3). Severe inflammation often led to partial loss of digits and foot pad
in untreated mice and foot pad in alcohol control (Fig. 4).
With ETE or curcumin treatment edema subsided and the paw with digits regained
normal size and appearance by the 9th day of resensitization (Fig.
4). However, in subsiding DTH response ETE seemed to do better job than
curcumin (Fig. 4).
||DNA histograms by FACS for cell cycle analysis of splenic
lymphocytes. (a) ETE treated, (b) curcumin treated, (c) alcohol treated
and (d) no treatment. M1-G0, M2-G1, M3-S and M4-G2
||Change in paw size of DTH mice with ETE and curcumin treatment
given intravenously, 1 h prior to resensitization (Day of resensitization
indicated by 0). There were alcohol treated and untreated controls. Results
are expressed as Mean±SD
Differential count at the inflammation site of the DTH mouse after treatment:
DTH reaction is mainly carried out by infiltrating lymphocytes, macrophages
and neutrophils from the venous and lymphatic system at the site of inflammation.
And thus to know what are the cell types that infiltrated at the site of inflammation
and the effect of ETE and curcumin treatment, differential count of leucocytes
was taken into account.
Increase in the percentage of lymphocytes and vis-à-vis decrease in neutrophils were noted in case of ETE and curcumin treatment than the control. Again, ETE did better in both the counts than curcumin. Although the monocyte counts remained comparable in experimental groups at 24, 48 h, an increase in the count at 48 h was observed in controls (Table 2). No appreciable change in the number of eosinophils and basophils occurred with ETE and curcumin treatment when compared to controls (Table 2).
CD4+ T-cell count in DTH mice after treatment: As the number of lymphocytes at the site of inflammation in mice bearing DTH response was considerably more with ETE and curcumin treatment over the alcohol and normal controls (Table 2), the contribution of CD4+ T-cells in this hike was studied from lymphocyte population of spleen from treated and control groups. Incidentally CD4+ T-cells are important participant in DTH response.
The count of CD4+ T-cells in spleen was indeed significantly higher in experimental groups, more so with ETE treatment (Fig. 5).
Inhibition of serum TNF-α level of DTH mice: The DTH response not only influences the recruitment of various leukocytes at the inflammatory site but also modulates secretion of various cytokines from these inflammatory cells. One such proinflammatory cytokine is TNF-α which plays significant role inflammatory reactions (Rossi and Zlotnik, 2000; Balkwill and Montovani, 2001). Quantification of it was carried out with ELISA in the present investigation.
ETE or curcumin injected intravenously 1 h prior to resensitization inhibited TNF-α production in DTH mice (Fig. 6). This is statistically significant when compared with the data of control groups.
Effect of ETE and curcumin on ROS
Inhibition of superoxide (O2¯) generation: Autoxidation
of hematoxylin leads to formation of hematein and is accompanied by an increasing
absorbance at 560 nm, indicating generation of O2¯ radical (Martin
et al., 1987). ETE could inhibit generation of O2¯ up
to 58.33%. The inhibition with curcumin and alcohol were about 28 and 16% respectively
Inhibition of lipid peroxidation: Copper-ascorbate induced lipid peroxidation and malonaldehyde (MDA) production within the cell was carried out for lymphocytes. H2O2 generation induces lipid peroxidation in the cell membrane which in turn produces MDA. Then effect of alcohol, ETE and curcumin on lipid peroxidation and MDA production was studied. ETE inhibits generation of H2O2 in lymphocytes (Fig. 7) up to 57.33%. Whereas, the inhibition by curcumin was even lower than the alcohol control.
Inhibition of hydroxyl radical (OH¯): The ETE also could inhibit hydroxyl radical generation upto 43% by restricting the Fentons reaction and generation of malonaldehyde (Fig. 7). The percentage of inhibition by curcumin was comparable to that with ETE treated ones. Alcohol did not show any inhibition in OH¯ radical generation.
Induction of NO¯ generation: The level of activity of cellular
enzyme Nitric Oxide Synthase (NOS) in generation of NO from L-arginine in murine
lymphocytes was maximum with ETE treatment as it could induce NO¯ generation
up to 17.2 pmol h-1, a few fold higher than other groups (Fig.
8). Curcumin caused no appreciable increment in NO- generation
over the control (Fig. 8).
||Photograph showing the DTH reaction of paw in (A) untreated,
(B) alcohol, (C) ETE and (D) curcumin treated mice in course of 9 days after
||Mean percentage of different leukocytes from the inflammation
site of paw, after 24 and 48 h of resensitization for DTH. The ETE and alcohol
were injected i.v.1 h prior to resensitization. Results are expressed as
Mean±SD, * p<0.05 and **p<0.01 compared to respective controls
|Percentage of Eosinophil and Basophil remained in a comparable
level in all the cases, in the range of 2-4%
Gene expression analysis: The level of expression of certain genes at
transcription level in presence of ETE, curcumin and in control was judged by
quantitating the cDNA PCR product amplified with specific primers. The quantitation
was done against 30 ng of lambda DNA as standard using ImageAide, Spectronics
ETE treatment caused a heightened expression of perforin, the effector molecule
to carry ouT-cell mediated immunity. It was almost double to that with curcumin
which could not elicit the response beyond controls (Fig. 9,
10). Therefore, it seems that ETE mediated activation might
elicit better cellular immune response. Similar results were observed in quantitation
of IL-2 primer amplified PCR product, rather curcumin seems to down regulate
expression of the gene (Fig. 9, 10).
||Count of CD4+ T-cells from spleen of DTH mice after
24 and 48 h of treatment with ETE and curcumin and of control mice. Results
are expressed as Mean±SD. Two way ANOVA revealed significant differences
of the values with ETE (p<0.01) and curcumin (p<0.05) to the controls
||Inhibition of serum TNF-α level in pg mL-1
by ETE and curcumin at 24 and 48 h of treatment of the mice undergoing DTH.
ELISA was used for quantitation. Two way ANOVA revealed differences of the
treatment values (ETE and curcumin) were significant to controls (p<0.01)
The higher level of expression of IL-6, another stimulatory cytokine, was observed
with ETE treatment and curcumin was not effective in this count. The amount
of PCR product with curcumin was comparable with the control ones (Fig.
9, 10). Both ETE and curcumin inhibited the expression
of TNF-α, a pro-inflammatory cytokine (Fig. 9, 10).
iNOS expression with ETE and curcumin treatment were marginally better than
the controls (Fig. 9, 10).
||Inhibition of Reactive Oxygen Species (ROS) generation by
ETE, curcumin and alcohol control. In case of OH¯ radical, alcohol
could not inhibit at all, so no representation by bar. *Denotes treatment
values were significant (p<0.01) to the controls
||Generation of NO in murine lymphocytes with ETE and curcumin
treatment. Two ANOVA revealed significant difference in NO generation with
ETE treatment (p<0.01)
In earlier investigations we showed ethanolic extract of turmeric rhizome (ETE)
activates lymphocytes and induce apoptosis in tumor cells (Chakravarty and Yasmin,
2005, 2008). Many other researchers have carried out several studies on anti-cancer
property of curcumin, the active constituent present in turmeric (Aggarwal et
al., 2003, 2004, 2006; Anto et al., 2002; Bharti et al., 2003a,
b; Choudhuri et al., 2002, 2005).
||Representation of mRNA expression of different genes on agarose
||Graphical representation of expression of different genes
with ETE and curcumin treatment compared to necessary controls. Significant
changes with ETE or curcumin treatment have marked *(p<0.01)
In the present investigation, the cell cycle analysis data shows ETE can drive
murine lymphocytes towards division better than curcumin (Table
1, Fig. 2). That is why the percentage of cells driven
to synthetic or S phase with turmeric is almost double to that induced with
curcumin. We and others showed earlier that division of lymphocytes is prerequisite
for functional differentiation of the cells (Chakravarty and Clark, 1977; Das
and Chakravarty, 1997). Marked differences in stimulation by ETE and curcumin
is also reflected in functional acumen of the activated cells in expression
of different genes, discussed later.
The ETE and curcumin were also found to inhibit delayed type hypersensitive
reaction and to help in regaining normalcy of foot pad; again ETE being superior
(Fig. 3, 4). The ETE inhibited inflammatory
phagocytic cell recruitment at inflammation site (Table 2)
slightly better than curcumin. This might help in subsiding the inflammation
related injury at DTH site, foot paw in our experiments. The ETE and curcumin
treatment of mice undergoing DTH caused higher CD4+ T-cell in splenic
population of lymphocytes (Fig. 5); in this account also ETE
was better performer. Normally TDTH cells belong to CD4+
type and contribute to the production of TNF-α. TNF-α is the most
important among different cytokines playing crucial ole in developing inflammation
reactions. Our results suggest increase in number of CD4+T-cells
may not necessarily contribute towards inflammation or production of TNF-α.
The level of this cytokine in serum was down along with inhibition of inflammation
with both ETE and curcumin treatment as estimated by ELISA (Fig.
6). In this context, down regulation of the expression of TNF-α gene
by ETE and curcumin as evidenced in our study (Fig. 9, 10)
seems to be immensely meaningful.
The effect of turmeric (ETE) and curcumin on generation of Reactive Oxygen Species (ROS) namely superoxide (O2¯), hydrogen peroxide (H2O2), hydroxyl (OH¯) and nitric oxide (NO¯) radicals has been looked into. The ROS play crucial roles in developing various pathophysiological conditions including inflammation and cancer (Bandhopadhy et al., 1999; Fruehauf and Meyskens Jr., 2007). The percentage of inhibition in O2¯ generation with ETE treatment was almost double to that of curcumin treated ones (Fig. 7). The ETE also could inhibit CuCl2-ascorbate derived H2O2 generation in murine lymphocytes by higher percentage over control; whereas the percentage of inhibition with curcumin treatment was even lower than the alcohol control (Fig. 7). Inhibition of OH- radical generation by ETE and curcumin as measured in Fentons reaction were comparable (Fig. 7). Thus, ETE is found to be effective anti-oxidant, at times better than curcumin.
NO¯ is pleiotropic molecule that acts as a messenger to mediate diverse
biological functions including cell division and differentiation (Niedbala et
al., 1999, 2002). The ETE induced NO generation in murine lymphocytes (Fig.
8) and up regulated inducible nitric oxide synthase (iNOS) gene in splenic
T-cells (Fig. 9, 10). Increase in the NO
production might contribute towards overall differentiation of lymphocytes for
better production of cytokines like IL-2, IL-6 and perforin molecules.
Thus ETE was found to be promoter of cell division and differentiation of murine lymphocytes, allowing them to secrete cytokines and to produce pore forming proteins for cytolytic ability. In all these events ETE performed better than commercial curcumin. The reflection of better efficacy of ETE over curcumin was also observed when we measured the expression of concerned genes, such as IL-2, IL-6 and perforin in assay with PCR product.
For the expression of IL-2, IL-6 and perforin curcumin could not elicit response beyond controls. This seems notable to establish superiority of ETE in induction of certain immunologically important genes over curcumin. Gao et al. (2004) and Xiaexhung and Xiaochung (2005) also showed curcumin to suppress development of cytotoxic T-cells (CTLs) and production of IL-2 in splenic T-cells.
Both ETE and curcumin down regulated TNF-α expression in mouse splenic
T-cells (Fig. 9, 10) clearly indicating
their anti-inflammatory property. The results presented in Fig.
3 and 4 documented anti-inflammatory property of ETE and
The present investigation allows recommending the use of turmeric for better result where curcumin has already been found to be effective. Therefore, a question will be why ETE performs better than curcumin in all the aspects investigated. Purification of curcumin eliminates several substances present in the whole extract of turmeric. Main component in curcumin is diferuloylmethane whereas whole extract of turmeric contains curcumin plus an antioxidant protein β-turmerin (Smitha et al., 2009), fats, minerals, carbohydrates, complex arabinogalactan and 2-7% essential oil. The essential oil consists of different sesquiterpenes viz., turmerone, ar-turmerone, zingiberene etc. (Leela et al., 2002). Some researchers observed anti-microbial (Miguel et al., 2002) and anti-inflammatory, wound healing, insecticidal activities (Negi et al., 1999) of this volatile curcuma oil which is essentially get lost in course of extraction of curcumin. Dohare et al. (2008) have found the curcuma oil to reduce nitrosative and oxidative stress. Raina et al. (2005), Srimal (1997), Nigam and Ahmad (1990) showed pinenes, eugenol and limonene in the turmeric essential oil participate specifically in the anti- inflammatory, anti-tumor activities. These components of whole rhizome extract of turmeric, some having specific anti-inflammatory and other biological activities, are left out in course of purification of commercial curcumin. These compounds in all likeliness have additive role for the immunotherapeutic value of ETE over curcumin.
The findings of this study provide a rationale for the general belief with
Ayurvedic practitioners that the crude extract acts better than the purified
compound from herbal sources in curing human ailments. An herbal medicine may
not signify a compound, rather it includes several minor chemical components
along with a main functional compound, as diferuloylmethane being main component
in turmeric. Interestingly the minor components seem to act in conjunction with
the major one. This may be taken into consideration to work with a bioactive
fraction from herbal source.
The use of total turmeric rhizome as we find in Indian subcontinent for cooking and taking directly for medicinal purposes is lot easier and cost effective when one considers the commercial value of curcumin around $20 for 20 capsules. We may add that, it is an age old common practice in India to have oral uptake of 5-10 g of turmeric rhizome with molasses in the morning in empty stomach; the present findings suggest rationale for this practice and recommend use of turmeric over curcumin whenever possible.
Authors are thankful to the University Grants Commission (UGC), India and Indian Council of Medical Research (ICMR), India for their financial assistance. Authors also express their heartfelt gratitude to Dr. Santu Bandyopahyay, IICB, Klkata, Dr. Arnab Sen, Department of Botany, NBU and Dr. Ranadhir Chakraborty, Department of Biotechnology, NBU to let us avail instrumental facilities in their laboratories. Researchers are also thankful to Dr. Bholanath Paul, IITR, Lucknow, India for providing valuable chemicals to carry out ELISA in his Laboratory.
1: Abe, Y., Y. Hashimoto and T. Horic, 1999. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol. Res., 39: 41-47.
2: Aggarwal, B.B., A. Kumar and A.C. Bharti, 2003. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res., 23: 363-398.
PubMed | Direct Link |
3: Aggarwal, S., H. Ichikawa, Y. Takada, S.K. Sandur, S. Shishodia and B.B. Aggarwal, 2006. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation. Mol. Pharmacol., 69: 195-206.
CrossRef | Direct Link |
4: Aggarwal, S., Y. Takada, S. Singh, J.N. Myers and B.B. Aggarwal, 2004. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor kappa B signaling. Int. J. Cancer, 111: 679-692.
5: Alin, A., 2006. Testing non-additivity (interaction) in two-way anova table with no replication. Stat. Methods Med. Res., 15: 63-85.
6: Ammon, H.P. and M.A. Wahl, 1991. Pharmacology of Curcuma longa. Planta Med., 57: 1-7.
7: Anto, R.J., A. Mukhopadhyay, K. Denning and B.B. Aggarwal, 2002. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23: 143-150.
CrossRef | PubMed | Direct Link |
8: Arora, R.B., V. Kapoor, N. Basu and A.P. Jain, 1971. Anti-inflammatory studies on Curcuma longa (Turmeric). Indian J. Med. Res., 59: 1289-1295.
9: Balkwill, F. and A. Mantovani, 2001. Inflammation and cancer: Back to virchow. Lancet, 357: 539-545.
Direct Link |
10: Bandyopadhyay, U., D. Das and R.K. Banerjee, 1999. Reactive oxygen species: Oxidative damage and pathogenesis. Curr. Sci., 77: 658-666.
Direct Link |
11: Berger, C.L. and R.L. Edelson, 1979. Comparison of lymphocyte function after isolation by ficoll hypaque flotation or elutriation. J. Invest. Dermatol., 73: 231-235.
12: Bharti, A.C., N. Donato and B.B. Aggarwal, 2003. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J. Immunol., 171: 3863-3871.
Direct Link |
13: Bharti, A.C., N. Donato, S. Singh and B.B. Aggarwal, 2003. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood, 101: 1053-1062.
14: Ramirez-Bosca, A., M.A. Carrion-Gutierrez, A. Soler, C. Puerta and A. Diez et al., 1997. Effects of the antioxidant turmeric on lipoprotein peroxides: Implications for the prevention of atherosclerosis. Age, 20: 165-168.
CrossRef | Direct Link |
15: Busch, R., D. Cesar, D. Higuera-Alhino, T. Gee, M.K. Hellerstein and J.M. McCune, 2004. Isolation of peripheral blood CD4+ T cells using RosetteSepTM and MACSTM for studies of DNA turnover by deuterium labeling. J. Immunol. Methods, 286: 97-109.
16: Chakravarty, A.K. and H. Yasmin, 2005. Alcoholic turmeric extract simultaneously activating murine lymphocytes and inducing apoptosis of Ehrlich`s Ascitic Carcinoma cells. Int. Immunopharmacol., 5: 1574-1581.
17: Chakravarty, A.K. and H. Yasmin, 2008. Free radical scavenging and nitric oxide synthase activation in murine lymphocytes and Ehrlich ascitic carcinoma cells treated with ethanolic extract of turmeric. Proc. Natl. Acad. Sci. India, 78: 37-44.
18: Chakravarty, A.K. and W.R. Clark, 1977. Lectin driven maturation of cytotoxic effector cells: The nature of effector memory. J. Exp. Med., 146: 230-240.
19: Chakravarty, A.K., H. Yasmin and S.K. Das, 2003. Two way efficacy of alcoholic turmeric extract: Stimulatory for murine lymphocytes and inhibitory for ascitic fibrosarcoma. Pharm. Biol., 42: 217-224.
20: Chan, M.M., 1995. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol., 49: 1551-1556.
21: Chandra, D. and S.S. Gupta, 1972. Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa (Haldi). Indian J. Med. Res., 60: 138-142.
22: Chen, A., J. Xu and A.C. Johnson, 2006. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of transcription factor Egr-1. Oncogene, 25: 278-287.
23: Chen, H.W., S.L. Yu, J.J. Chen, H.N. Li and Y.C. Lin et al., 2004. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol. Pharmacol., 65: 99-110.
Direct Link |
24: Cheshire, J.L. and A.S. Baldwin Jr., 1997. Synergistic activation of NF-B by tumor necrosis factor alpha and gamma interferon via enhanced IkBα degradation and de novo IkBβ degradation. Mol. Cell Biol., 17: 6746-6754.
25: Choudhuri, T., S. Pal, M.L. Aggarwal, T. Das and G. Sa, 2002. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett., 512: 334-340.
CrossRef | PubMed | Direct Link |
26: Choudhuri, T., S. Pal, T. Das and G. Sa, 2005. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem., 280: 20059-20068.
CrossRef | PubMed | Direct Link |
27: Chaudhuri, T.K. and A.K. Chakravarty, 1983. Goat serum as a substitute for fetal calf serum in in vitro culture of murine lymphocytes. Indian J. Exp. Biol., 21: 494-496.
28: Das, S.K. and A.K. Chakravarty, 1997. Characterization of primed lymphocytes on the basis of sensitivity of chromatin to DNase I. Indian J. Exp. Biol., 54: 1156-1160.
29: Daube, F.V., 1870. Uber curcumin, den farbstoff der curcumawurzel. Berichte Deutschen Chemischen Gesellschaft, 3: 609-613.
Direct Link |
30: Dohare, P., P. Garg, U. Sharma, N.R. Jagannathan and M. Ray, 2008. Neuroprotective efficacy and therapeutic window of curcuma oil: In rat embolic stroke model. BMC Complementary Alternative Med., 8: 55-74.
31: Fruehauf, J.P. and F.L. Meyskens Jr., 2007. Reactive oxygen species: A breath of life or death?. Clin Cancer Res., 13: 789-794.
32: Gao, X., J. Kuo, H. Jiang, D. Deeb and Y. Liu et al., 2004. Immunomodulatory activity of curcumin: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity and cytokine production in vitro. Biochem. Pharmacol., 68: 51-61.
33: Grant, K.L., 2000. Alternative therapies: Turmeric. Am. J. Health Syst. Pharm., 57: 1121-1122.
34: Gulucubuk, A., K. Altunatmaz, K. Sonmez, D. Haktanir-Yatkin and H. Uzun et al., 2006. Effects of curcumin on tumor necrosis factor-α and interleukin-6 in the late phase of experimental acute pancreatitis. J. Vet. Med. Ser. A, 53: 49-54.
35: Henkart, P.A., 1989. Mechanisms of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol., 3: 31-58.
36: Iizima, M. and S.I. Katz, 1983. Specific immunologic tolerance to dinitrofluorobenzene following topical application of dinitrothyocyanobenzene: Mulation by suppressor T cells. J. Invest. Dermatol., 81: 325-330.
37: Jia, L., C. Bonaventua, J. Bonaventura and J.S. Stamler, 1996. S-nitrosohemoglobulin: A dynamic activity of blood involved in vascular control. Nature, 380: 221-226.
38: Jobin, C., C.A. Bradhan, M.P. Russo, B. Juma, A.S. Narula and D.A. Brenner, 1999. Curcumin blocks cytokine mediated NF-kB activation and proinflammatory gene expression by inhibiting factor IkB activity. J. Immunol., 163: 3474-3483.
39: Julius, M., E. Simpson and A.L. Herzenberg, 1973. A rapid method for isolation of functional thymus derived murine lymphocytes. Eur. J. Immuno., 3: 645-649.
40: Kagi, D., B. Ledermann, K. Burki, P. Seiler and B. Odermatt et al., 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature, 369: 31-37.
41: Koide, T., M. Nose, Y. Ogihara, Y. Yabu and N. Ohta, 2002. Leishmanicidal effect of curcumin in vitro. Biol. Pharm. Bull., 25: 131-133.
42: Kuttan, R., P. Bhanumathy, K. Nirmala and M.C. George, 1985. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett., 29: 197-202.
43: Leela, N.K., A. Tava, P.M. Shafi, S.P. John and B. Chempakam, 2002. Chemical composition of essential oils of turmeric (Curcuma longa L.). Acta Pharm., 52: 137-141.
44: Mace, F.K., J. Ehrke, K. Hori and D.L. Maccubbin, 1988. Role of tumor necrosis factor in macrophage activation and tumoricidal activity. Cancer Res., 48: 5427-5432.
45: Martin, Jr. J.P., M. Dailey and E. Sugarman, 1987. Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch. Biochem. Biophys., 255: 329-336.
46: Matheu, M.P. and M.D. Cahalan, 2007. Isolation of CD4+ T cells from mouse lymph nodes using miltenyi MACS purification. J. Vis. Exp., 2007: 409-409.
CrossRef | PubMed | Direct Link |
47: Miquel, J., A. Bernd, J.M. Sempere, J. Diaz-Alperi and A. Ramirez, 2002. The curcuma antioxidants: Pharmacological effects and prospects for future clinical use. A review. Arch. Gerontol. Geriatr., 34: 37-46.
PubMed | Direct Link |
48: Miller, D.M. and S.D. Aust, 1989. Studies of ascorbate dependent, iron-catalyzed lipid peroxidation. Arch. Biochem. Biophys., 271: 113-119.
49: Mukundan, M.A., M.C. Chacko, V.V. Annapurna and K. Krishnaswammy, 1993. Effect to turmeric and curcumin on BP-DNA adducts. Carcinogenesis, 14: 493-496.
50: Negi, P.S., G.K. Jayaprakash, L. Jagan-Mohan-Rao and K.K. Sakaria, 1999. Anti-bacterial activity of turmeric oil: A byproduct from curcumin manufacture. J. Agric. Food Chem., 47: 4297-4300.
51: Niedbala, W., X.Q. Wei, C. Campbell, D. Thomson, M. Komai-Koma and F.Y. Liew, 2002. Nitric oxide preferentially induces type 1 T cell differentiation by selectively up regulating IL-12 receptor 2 expression via cGMP. Proc. Natl. Acad. Sci. USA., 99: 16186-16191.
Direct Link |
52: Niedbala, W., X.Q. Wei, D. Piedrafita, D. Xu and F.Y. Liew, 1999. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur. J. Immunol., 29: 2498-2505.
53: Nigam, M.C. and A. Ahmad, 1990. Curcuma longa terpenoid composition of its essential oil. Indian Perfumer, 35: 255-257.
54: Rafatullah, S., M. Tariq, M.A. Al-Yahya, J.S. Mossa and A.M. Ageel, 1990. Evaluation of turmeric (Curcuma longa) for gastric and duodenal anti-ulcer activity in rats. J. Ethnopharmacol., 29: 25-34.
55: Raina, V.K., S.K. Srivastava and K.V. Syamsundar, 2005. Rhizome and leaf oil composition of curcuma longa from the lower Himalayan Region of Northern India. J. Essential Oil Res., 17: 556-559.
56: Rappolee, D.A., C.A. Brenner, R. Schultz, D. Mark and Z. Werb, 1988. Developmental expression of PDGF, TGF-alpha and TGF-beta genes in preimplantation mouse embryos. Science, 241: 1823-1825.
57: Rasmussen, H.B., S.B. Christensen, L.P. Kvist and A. Karazmi, 2000. A simple and effective separation of the curcumins, the anti-protozoal constituents of Curcuma longa. Planta Med., 66: 396-398.
58: Rossi, D. and A. Zlotnik, 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol., 18: 217-242.
59: Roughley, P.J. and D.A. Whiting, 1973. Experiments in the biosynthesis of curcumin. J. Chem. Soc. Perkin Trans., 20: 2379-2388.
Direct Link |
60: Samy, R.P., P.N. Pushparaj and P. Gopalakrishnakone, 2008. A compilation of bioactive compounds from ayurveda. Bioinformation, 3: 100-110.
Direct Link |
61: Satoskar, R.R., S.J. Shah and S.G. Shenoy, 1986. Evaluation of the anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int. J. Clin. Pharmacol. Ther. Toxicol., 24: 651-654.
62: Selvam, R., L. Subramanian, R. Gayathri and N. Angayarkanni, 1995. The anti-oxidant activity of turmeric (Curcuma longa). J. Ethnopharmacol., 47: 59-67.
63: Sharma, R.A., H.R. McLelland, K.A. Hill, C.R. Ireson and S.A. Euden et al., 2001. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res., 7: 1894-1900.
64: Siddiqui, A.M., X. Cui, R. Wu, W. Dong, M. Zhou and M. Hu et al., 2006. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit. Care Med., 34: 1874-1884.
Direct Link |
65: Singh, S. and B.B. Aggarwal, 1995. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem., 270: 24995-25000.
PubMed | Direct Link |
66: Sirish-Kumar, I.V.M.L.R., B.N. Paul, R. Asthama, A.K. Saxena, S. Mehrotra and G. Rajan, 2003. Swertia chirayita mediated modulation of interleukin-1, interleukin-6, interleukin-10, interferon-and tumor necrosis factorα in arthritic mice. Immunopharmacol. Immunotoxicol., 25: 573-583.
Direct Link |
67: Smitha, S., B.L. Dhananjaya, R. Dinesha and L. Sinivas, 2009. Purification and characterization of a ~34 kDa protein (β-turmerin) from turmeric (Curcuma longa) waste grits. Biochimie, 91: 1156-1162.
CrossRef | PubMed | Direct Link |
68: Srimal, R.C., 1997. Turmeric a brief review of medicinal properties. Fitoterapia, 68: 483-493.
69: Srivastava, K.C., A. Bordia and S.K. Verma, 1995. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukotrienes Essent. Fatty Acids, 52: 223-227.
CrossRef | PubMed | Direct Link |
70: Stanciu, L.A. and R. Djukanovic, 2000. Isolation of T cell subsets by magnetic cell sorting. Methods Mol. Biol., 134: 133-133.
71: Stockinger, B. and M. Veldhoen, 2007. Differentiation and function of Th17 T cells. Curr. Opin. Immunol., 19: 281-286.
72: Tamul, K.R., J.L. Schimtz, K. Kane and J.D. Folds, 1995. Comparison of the effects of ficoll-hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic Malignancies. Clin. Diagnostic Lab. Immunol., 2: 337-342.
73: Thangapazham, R.L., A. Sharma and R.K. Maheshwari, 2006. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J., 8: E443-E449.
74: Thiemermann, C., 2006. The spice of life: Curcumin reduces the mortality associated with Experimental sepsis. Crit. Care Med., 34: 2009-2011.
75: Torisu, H., M. Ono, H. Kiryu, M. Furue and Y. Ohmoto et al., 2000. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNF-α and IL-1β. Int. J. Cancer, 85: 182-188.
Direct Link |
76: Tschopp, J. and M. Nabholz, 1990. Perforin mediated target cell lysis by cytolytic T lymphocytes. Annu. Rev. Immunol., 8: 279-302.
77: Voskoboinik, I. and J.A. Trapani, 2006. Addressing the mysteries of perforin function. Immunol. Cell Biol., 84: 66-71.
78: Xinjian, L. and L. Xiaochung, 2005. Effect of curcumin on immune function of mice. J. Huazhong Univ. Sci. Technol. Med. Sci., 25: 137-140.
79: Yamamoto, H., K. Hanada, K. Kawasaki and M. Nishijima, 1997. Inhibitory effect of curcumin on mammalian phospholipase D activity. FEBS Lett., 417: 196-198.
80: Yasmin, H., 2007. Analysis of the effects of Curcuma longa Linn. on lymphocytes and malignant cells in murine model for immunotherapy. Ph.D. Thesis, University of North Bengal, Sliguri, India.
81: Young, J.D., 1989. Killing of target cells by lymphocytes: A mechanistic view. Physiol. Rev., 69: 250-314.
Direct Link |
82: Halliwell, B., J.M.C. Gutteridge and O.I. Aruoma, 1987. The deoxyribose method: A simple test-tube assay for determination of rate constants for reactions of hydroxyl radicals. Anal. Biochem., 165: 215-219.
CrossRef | Direct Link |